Fund Holdings — Artia Global Partners LP

Total Portfolio Value
$388.82M
Total Bought
$175.05M
Total Sold
$139.09M
Net Transaction
+$35.96M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
VERONA PHARMA PLC538,488924,204+385,71634,18987,41122.48%+53,223
INSMED INC(INSM)318,239752,712+434,47324,27875,75319.48%+51,474
ARGENX SE(ARGX)11,31178,311+67,0006,69543,16711.10%+36,472
TREVI THERAPEUTICS INC(TRVI)01,311,840+1,311,84007,1761.85%+7,176
SOLENO THERAPEUTICS INC498,473494,424-4,04935,61641,42310.65%+5,807
REGENERON PHARMACEUTICALS(REGN)010,671+10,67105,6021.44%+5,602
QUEST DIAGNOSTICS INC(DGX)56,71781,717+25,0009,59714,6793.78%+5,082
BOSTON SCIENTIFIC CORP(BSX)129,700155,200+25,50013,08416,6704.29%+3,586
ABBVIE INC(ABBV)014,500+14,50002,6910.69%+2,691
VERTEX PHARMACEUTICALS INC(VRTX)04,400+4,40001,9590.50%+1,959
ULTRAGENYX PHARMACEUTICAL IN(RARE)041,830+41,83001,5210.39%+1,521
EYEPOINT PHARMACEUTICALS INC(EYPT)316,700316,70001,7172,9800.77%+1,264
BIOHAVEN LTD(BHVN)080,000+80,00001,1290.29%+1,129
AVIDITY BIOSCIENCES INC034,600+34,60009830.25%+983
ASCENDIS PHARMA A/S(ASND)7,44012,240+4,8001,1602,1130.54%+953
KINIKSA PHARMACEUTICALS INTL(KNSA)029,200+29,20008080.21%+808
SPRINGWORKS THERAPEUTICS INC53,93063,930+10,0002,3803,0040.77%+624
MINERALYS THERAPEUTICS INC(MLYS)041,100+41,10005560.14%+556
NEWAMSTERDAM PHARMA COMPANY
ORDINARY SHARES
027,319+27,31904950.13%+495
VIKING THERAPEUTICS INC(VKTX)90,27996,479+6,2002,1802,5570.66%+376
MEREO BIOPHARMA GROUP PLC(MREO)421,359475,361+54,0029481,2880.33%+340
REVOLUTION MEDICINES INC(RVMD)104,190104,19003,6843,8330.99%+149
ORUKA THERAPEUTICS INC(ORKA)7,3800-7,380760—-76
XENON PHARMACEUTICALS INC(XENE)40,00040,00001,3421,2520.32%-90
TRAVERE THERAPEUTICS INC(TVTX)30,90030,90005544570.12%-96
UNITED THERAPEUTICS CORP DEL(UTHR)5,0005,00001,5411,4370.37%-105
TG THERAPEUTICS INC(TGTX)54,51554,51502,1501,9620.50%-188
CENTESSA PHARMACEUTICALS PLC35,2260-35,2265070—-507
JANUX THERAPEUTICS INC(JANX)38,10020,000-18,1001,0294620.12%-567
ASTRAZENECA PLC(AZN)190,752190,752014,02013,3303.43%-691
ALNYLAM PHARMACEUTICALS INC(ALNY)28,60020,970-7,6307,7236,8381.76%-884
SCHOLAR ROCK HLDG CORP(SRRK)172,185126,285-45,9005,5364,4731.15%-1,063
NEUROCRINE BIOSCIENCES INC(NBIX)14,7000-14,7001,6260—-1,626
INTUITIVE SURGICAL INC3,5000-3,5001,7330—-1,733
VIRIDIAN THERAPEUTICS INC(VRDN)160,0000-160,0002,1570—-2,157
MERUS N V424,640296,750-127,89017,87315,6094.01%-2,264
RHYTHM PHARMACEUTICALS INC(RYTM)50,0000-50,0002,6490—-2,648
NUVALENT INC90,7450-90,7456,4360—-6,436
PROTAGONIST THERAPEUTICS INC333,85122,951-310,90016,1451,2690.33%-14,877
ARCELLX INC
COMMON STOCK
229,0850-229,08515,0280—-15,028
INTRA-CELLULAR THERAPIES INC219,7190-219,71928,9850—-28,985
ELI LILLY & CO(LLY)94,88730,700-64,18778,36823,9326.15%-54,437
Page 1 of 1
Artia Global Partners LP — 13F Holdings — Q2 2025 | TickerTrail